Rainier Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-34,690
Closed -$1.01M 83
2017
Q3
$1.01M Sell
34,690
-10,970
-24% -$303K 0.24% 125
2017
Q2
$1.27M Sell
45,660
-29,760
-39% -$790K 0.25% 128
2017
Q1
$1.88M Buy
+75,420
New +$1.83M 0.2% 140
2016
Q4
Sell
-684,320
Closed -$16.3M 155
2016
Q3
$16.3M Sell
684,320
-264,800
-28% -$6.32M 1.05% 22
2016
Q2
$22.2M Sell
949,120
-62,340
-6% -$1.35M 1.07% 15
2016
Q1
$19M Buy
+1,011,460
New +$17.8M 0.85% 29

Other funds holding BSX

Rainier Investment Management's BSX Position: Q4 2017 in Review

Rainier Investment Management sold out of Boston Scientific (BSX) in Q4 2017, closing a stake of 34,690 shares — an estimated $1.01M sold.

Rainier Investment Management first reported a position in BSX in Q1 2016 and held it in 6 quarters. The position peaked at $22.2M in Q2 2016. 632 funds tracked by Wall St. Rank hold BSX as of Q4 2017.

  • Rainier Investment Management reported no remaining Boston Scientific position as of Q4 2017 after selling out during the quarter.
  • Rainier Investment Management sold 34,690 Boston Scientific shares in Q4 2017, an estimated $1.01M.
  • Rainier Investment Management first reported a position in Boston Scientific in Q1 2016 and held it in 6 quarters.
  • Rainier Investment Management's Boston Scientific position peaked at $22.2M in Q2 2016.
  • 632 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2017.

Based on Rainier Investment Management's 13F filing for Q4 2017, filed 2 Feb 2018.